Amdekar Y K
B. J. Wadia Hospital for Children, Mumbai, India,
Indian J Pediatr. 2014 Jan;81(1):36-41. doi: 10.1007/s12098-013-1296-0. Epub 2013 Nov 30.
Clinical manifestations of disease depend upon host's immune response that is induced by pathogen and modified by the host's innate and adaptive immunity. Immunocompetent children of similar age and nutrition evoke different responses to the same pathogen varying from benign to potentially fatal condition. This results in diverse clinical presentations of a disease, that is different from the standard expected pattern and thus, poses a diagnostic challenge. Even, subsequent progression of a disease is also variable. It is the balance between immune stimulation, immune suppression and immune tolerance that decides the outcome. In case of balanced response, child recovers completely without any damage. However at times, cure is at the expense of permanent sequalae while in case of unfavourable immune response, survival may not be certain inspite of successful therapy. Symptoms and physical signs of primary disease often overlap with those caused by host's immune response. In such a situation, it is difficult to decide whether therapy of primary disease has failed due to drug resistance or whether persistence or deterioration is the result of immune response. Occasionally pathogen can transform into "superantigen" that may lead to "cytokine storm". Resulting immune-mediated complications may endanger life and at best, treated symptomatically. Immune suppressive drugs such as steroids, chemotherapeutic agents, IVIG or specific antibodies may not be able to suppress undesirable immune response. It is not just the immune suppression that is required but ideally immune modulation. Immune modulation refers to enhancing protective responses while avoiding destructive ones. At present, science falls short of anticipating harmful immune responses and lacks specific immune intervention.Laboratory test results are also dependent on host response and hence need cautious interpretation based on clinical profile in consideration with multiple variables. In final analysis, fight between host and pathogen is a complex one and often unpredictable. It is hoped that most children evoke favourable response but pediatrician has to be watchful even in the most benign disease.
疾病的临床表现取决于宿主的免疫反应,这种免疫反应由病原体诱导,并受到宿主固有免疫和适应性免疫的调节。年龄和营养状况相似的免疫功能正常儿童对同一种病原体可产生不同反应,从良性状态到潜在的致命状况不等。这导致疾病的临床表现多种多样,与标准预期模式不同,因此带来了诊断挑战。甚至,疾病的后续进展也存在变数。免疫刺激、免疫抑制和免疫耐受之间的平衡决定了最终结果。在反应平衡的情况下,儿童可完全康复而无任何损伤。然而,有时治愈是以永久性后遗症为代价的,而在免疫反应不利的情况下,尽管治疗成功,生存也未必确定。原发性疾病的症状和体征常与宿主免疫反应引起的症状和体征重叠。在这种情况下,很难确定原发性疾病的治疗失败是由于耐药性,还是持续存在或病情恶化是免疫反应的结果。病原体偶尔可转化为“超抗原”,可能导致“细胞因子风暴”。由此产生的免疫介导并发症可能危及生命,充其量只能进行对症治疗。免疫抑制药物,如类固醇、化疗药物、静脉注射免疫球蛋白或特异性抗体,可能无法抑制不良免疫反应。不仅需要免疫抑制,理想的是进行免疫调节。免疫调节是指增强保护性反应,同时避免破坏性反应。目前,科学尚无法预测有害的免疫反应,也缺乏特异性免疫干预措施。实验室检查结果也取决于宿主反应,因此需要根据临床情况,综合考虑多个变量进行谨慎解读。归根结底,宿主与病原体之间的斗争是复杂的,往往不可预测。希望大多数儿童能产生良好反应,但即使是最良性的疾病,儿科医生也必须保持警惕。